{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:43:44Z","timestamp":1787028224391,"version":"build-2736575974"},"reference-count":271,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000785"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000785"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["LO1609"],"award-info":[{"award-number":["LO1609"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>National cancer databases document that melanoma is the most aggressive and deadly cutaneous malignancy with worldwide increasing incidence in the Caucasian population. Around 10% of melanomas occur in families. Several germline mutations were identified that might help to indicate individuals at risk for preventive interventions and early disease detection. More than 50% of sporadic melanomas carry mutations in Ras\/Raf\/mitogen-activated protein kinase (MAPK\/MEK) pathway, which may represent aims of novel targeted therapies. Despite advances in targeted therapies and immunotherapies, the outcomes in metastatic tumor are still unsatisfactory. Here, we review animal models that help our understanding of melanoma development and treatment, including non-vertebrate, mouse, swine, and other mammal models, with an emphasis on those with spontaneously developing melanoma. Special attention is paid to the melanoma-bearing Libechov minipig (MeLiM). This original swine model of hereditary metastatic melanoma enables studying biological processes underlying melanoma progression, as well as spontaneous regression. Current histological, immunohistochemical, biochemical, genetic, hematological, immunological, and skin microbiome findings in the MeLiM model are summarized, together with development of new therapeutic approaches based on tumor devitalization. The ongoing study of molecular and immunological base of spontaneous regression in MeLiM model has potential to bring new knowledge of clinical importance.<\/jats:p>","DOI":"10.3390\/genes10110915","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T04:07:07Z","timestamp":1573531627000},"page":"915","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Melanoma-Bearing Libechov Minipig (MeLiM): The Unique Swine Model of Hereditary Metastatic Melanoma"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5878-3138","authenticated-orcid":false,"given":"Vratislav","family":"Horak","sequence":"first","affiliation":[{"name":"Czech Academy of Sciences, Institute of Animal Physiology and Genetics, Laboratory of Applied Proteome Analyses and Research Center PIGMOD, 277 21 Libechov, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2311-0697","authenticated-orcid":false,"given":"Anna","family":"Palanova","sequence":"additional","affiliation":[{"name":"Czech Academy of Sciences, Institute of Animal Physiology and Genetics, Laboratory of Applied Proteome Analyses and Research Center PIGMOD, 277 21 Libechov, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Cizkova","sequence":"additional","affiliation":[{"name":"Czech Academy of Sciences, Institute of Animal Physiology and Genetics, Laboratory of Applied Proteome Analyses and Research Center PIGMOD, 277 21 Libechov, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Miltrova","sequence":"additional","affiliation":[{"name":"Czech Academy of Sciences, Institute of Animal Physiology and Genetics, Laboratory of Applied Proteome Analyses and Research Center PIGMOD, 277 21 Libechov, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6605-9158","authenticated-orcid":false,"given":"Petr","family":"Vodicka","sequence":"additional","affiliation":[{"name":"Czech Academy of Sciences, Institute of Animal Physiology and Genetics, Laboratory of Applied Proteome Analyses and Research Center PIGMOD, 277 21 Libechov, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0591-5018","authenticated-orcid":false,"given":"Helena","family":"Kupcova Skalnikova","sequence":"additional","affiliation":[{"name":"Czech Academy of Sciences, Institute of Animal Physiology and Genetics, Laboratory of Applied Proteome Analyses and Research Center PIGMOD, 277 21 Libechov, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4065\/81.4.500","article-title":"Cutaneous Malignant Melanoma","volume":"81","author":"Cummins","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A Systematic Review of Worldwide Incidence of Nonmelanoma Skin Cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.mpmed.2017.04.003","article-title":"Skin Cancer","volume":"45","author":"Craythorne","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.14336\/AD.2017.0503","article-title":"Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology","volume":"8","author":"Garcovich","year":"2017","journal-title":"Aging Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/pdia.2013.33376","article-title":"Skin Melanocytes: Biology and Development","volume":"30","author":"Cichorek","year":"2013","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1200\/JCO.2008.20.7258","article-title":"Neonatal Congenital Malignant Melanoma with Lymph Node Metastasis","volume":"27","author":"McElearney","year":"2009","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4065\/72.3.273","article-title":"Dermatopathologic Variants of Malignant Melanoma","volume":"72","author":"Perniciaro","year":"1997","journal-title":"Mayo Clin. Proc."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, K., Bhatia, A., Tsen, F., Chen, M., Wong, A.K., Woodley, D.T., and Li, W. (2014). Identification of the Critical Therapeutic Entity in Secreted Hsp90\u03b1 that Promotes Wound Healing in Newly Re-Standardized Healthy and Diabetic Pig Models. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113956"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molimm.2014.10.023","article-title":"The Immunology of the Porcine Skin and its Value as a Model for Human Skin","volume":"66","author":"Summerfield","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.27616","article-title":"International Trends in the Incidence of Malignant Melanoma 1953\u20132008-Are Recent Generations at Higher or Lower Risk?","volume":"132","author":"Erdmann","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous Melanoma","volume":"383","author":"Eggermont","year":"2014","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer Statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_13","first-page":"1005","article-title":"Melanoma: Epidemiology, Risk Factors, Pathogenesis, Diagnosis and Classification","volume":"28","author":"Rastrelli","year":"2014","journal-title":"Vivo Athens Greece"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-319-22539-5_2","article-title":"Melanoma Epidemiology and Prevention","volume":"167","author":"Berwick","year":"2016","journal-title":"Cancer Treat. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10555-017-9661-5","article-title":"Identification, Genetic Testing, and Management of Hereditary Melanoma","volume":"36","author":"Leachman","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/oxfordjournals.aje.a113175","article-title":"A Genetic Analysis of Melanoma--Polygenic Inheritance as a Threshold Trait","volume":"114","author":"Duggleby","year":"1981","journal-title":"Am. J. Epidemiol."},{"key":"ref_17","first-page":"3995","article-title":"Loss of Heterozygosity at Autosomal and X-Linked Loci During Tumor Progression in a Patient with Melanoma","volume":"47","author":"Dracopoli","year":"1987","journal-title":"Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1073\/pnas.89.21.10557","article-title":"Homozygous Deletions within Human Chromosome Band 9p21 in Melanoma","volume":"89","author":"Fountain","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","first-page":"936","article-title":"Confirmation of Chromosome 9p Linkage in Familial Melanoma","volume":"53","author":"Nancarrow","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng0994-22","article-title":"Analysis of the p16 Gene (CDKN2) as a Candidate for the Chromosome 9p Melanoma Susceptibility Locus","volume":"8","author":"Kamb","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_21","first-page":"2497","article-title":"Novel Germline p16 Mutation in Familial Malignant Melanoma in Southern Sweden","volume":"56","author":"Borg","year":"1996","journal-title":"Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1073\/pnas.93.16.8541","article-title":"Prevalence of Germ-Line Mutations in p16, p19ARF, and CDK4 in Familial Melanoma: Analysis of a Clinic-Based Population","volume":"93","author":"FitzGerald","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/hmg\/6.12.2061","article-title":"Germline Mutations of the CDKN2 Gene in UK Melanoma Families","volume":"6","author":"Harland","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","article-title":"Prevalence of p16 and CDK4 Germline Mutations in 48 Melanoma-Prone Families in France. The French Familial Melanoma Study Group","volume":"7","author":"Soufir","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jnci\/91.5.446","article-title":"CDKN2A Variants in a Population-Based Sample of Queensland Families with Melanoma","volume":"91","author":"Aitken","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","article-title":"Alternative Reading Frames of the INK4a Tumor Suppressor Gene Encode two Unrelated Proteins Capable of Inducing Cell Cycle Arrest","volume":"83","author":"Quelle","year":"1995","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","article-title":"The Alternative Product from the Human CDKN2A Locus, p14(ARF), Participates in a Regulatory Feedback Loop with p53 and MDM2","volume":"17","author":"Stott","year":"1998","journal-title":"EMBO J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features Associated with Germline CDKN2A Mutations: A GenoMEL Study of Melanoma-Prone Families from Three Continents","volume":"44","author":"Goldstein","year":"2007","journal-title":"J. Med. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5826\/dpc.0901a03","article-title":"Familial Melanoma: Diagnostic and Management Implications","volume":"9","author":"Rossi","year":"2019","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1897-4287-12-20","article-title":"Prevalence and Predictors of Germline CDKN2A Mutations for Melanoma Cases from Australia, Spain and the United Kingdom","volume":"12","author":"Harland","year":"2014","journal-title":"Hered. Cancer Clin. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.7652577","article-title":"A p16INK4a-Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma","volume":"269","author":"Wolfel","year":"1995","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","article-title":"Germline Mutations in the p16INK4a Binding Domain of cdk4 in Familial Melanoma","volume":"12","author":"Zuo","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/jmedgenet-2012-101455","article-title":"Melanoma Prone Families with CDK4 Germline Mutation: Phenotypic Profile and Associations with MC1R Variants","volume":"50","author":"Puntervoll","year":"2013","journal-title":"J. Med. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline Mutations in BAP1 Predispose to Melanocytic Tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Njauw, C.N.J., Kim, I., Piris, A., Gabree, M., Taylor, M., Lane, A.M., DeAngelis, M.M., Gragoudas, E., Duncan, L.M., and Tsao, H. (2012). Germline BAP1 Inactivation is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035295"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/PAT.0b013e3283653818","article-title":"BAP1 Expression in Cutaneous Melanoma: A Pilot Study","volume":"45","author":"Murali","year":"2013","journal-title":"Pathol. J. PCPA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-13-3109","article-title":"Germline Mutations in BAP1 Impair its Function in DNA Double-Strand Break Repair","volume":"74","author":"Ismail","year":"2014","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2015.08.037","article-title":"Hereditary Melanoma: Update on Syndromes and Management: Emerging Melanoma Cancer Complexes and Genetic Counseling","volume":"74","author":"Soura","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT Promoter Mutations in Familial and Sporadic Melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.2947","article-title":"POT1 Loss-of-Function Variants Predispose to Familial Melanoma","volume":"46","author":"Harland","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.2941","article-title":"Rare Missense Variants in POT1 Predispose to Familial Cutaneous Malignant Melanoma","volume":"46","author":"Shi","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/bjd.17443","article-title":"POT1 Germline Mutations but Not TERT Promoter Mutations are Implicated in Melanoma Susceptibility in a Large Cohort of Spanish Melanoma Families","volume":"181","author":"Potrony","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"dju408","DOI":"10.1093\/jnci\/dju408","article-title":"Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma","volume":"107","author":"Aoude","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0092-8674(93)90429-T","article-title":"Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein","volume":"74","author":"Hodgkinson","year":"1993","journal-title":"Cell"},{"key":"ref_46","first-page":"8058","article-title":"Microphthalmia Associated Transcription Factor as a Regulator for Melanocyte-Specific Transcription of the Human Tyrosinase Gene","volume":"14","author":"Yasumoto","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1158\/0008-5472.CAN-07-6622","article-title":"Microphthalmia-Associated Transcription Factor is a Critical Transcriptional Regulator of Melanoma Inhibitor of Apoptosis in Melanomas","volume":"68","author":"Dynek","year":"2008","journal-title":"Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative Genomic Analyses Identify MITF as a Lineage Survival Oncogene Amplified in Malignant Melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-Defective MITF Germline Mutation Predisposes to Melanoma and Renal Carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/302711","article-title":"Melanocortin-1 Receptor Polymorphisms and Risk of Melanoma: Is the Association Explained Solely by Pigmentation Phenotype?","volume":"66","author":"Palmer","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.0022-202x.2001.01421.x","article-title":"Melanocortin 1 Receptor (MC1R) Gene Variants are Associated with an Increased Risk for Cutaneous Melanoma which is Largely Independent of Skin Type and Hair Color","volume":"117","author":"Kennedy","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/323412","article-title":"MC1R Genotype Modifies Risk of Melanoma in Families Segregating CDKN2A Mutations","volume":"69","author":"Box","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_53","first-page":"64","article-title":"Vitamin D and Melanoma: State of the Art and Possible Therapeutic Uses","volume":"154","author":"Paolino","year":"2019","journal-title":"G. Ital. Dermatol. E Venereol. Organo Uff. Soc. Ital. Dermatol. E Sifilogr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/labinvest.2017.3","article-title":"Vitamin D Signaling and Melanoma: Role of Vitamin D and its Receptors in Melanoma Progression and Management","volume":"97","author":"Slominski","year":"2017","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"ref_55","first-page":"498","article-title":"Vitamin D Receptor Polymorphisms are Associated with Altered Prognosis in Patients with Malignant Melanoma","volume":"6","author":"Hutchinson","year":"2000","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(02)07600-6","article-title":"Association between Functional Polymorphism in EGF Gene and Malignant Melanoma","volume":"359","author":"Shahbazi","year":"2002","journal-title":"Lancet Lond. Engl."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1038\/sj.onc.1206445","article-title":"Genetics of Melanoma Predisposition","volume":"22","author":"Hayward","year":"2003","journal-title":"Oncogene"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/14737140.6.5.657","article-title":"High-And Low-Penetrance Cutaneous Melanoma Susceptibility Genes","volume":"6","author":"Fargnoli","year":"2006","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/pcmr.12333","article-title":"Genetics of Familial Melanoma: 20 Years after CDKN2A","volume":"28","author":"Aoude","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/pcmr.12422","article-title":"Genetics of Melanoma Progression: The Rise and Fall of Cell Senescence","volume":"29","author":"Bennett","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Roberts, M.R., Asgari, M.M., and Toland, A.E. (2019). Genome-Wide Association Studies and Polygenic Risk Scores for Skin Cancer: Clinically Useful Yet?. Br. J. Dermatol.","DOI":"10.1111\/bjd.18576"},{"key":"ref_62","first-page":"37","article-title":"Genetics of Pigmentation and Melanoma Predisposition","volume":"145","author":"Pho","year":"2010","journal-title":"G. Ital. Dermatol. E Venereol. Organo Uff. Soc. Ital. Dermatol. E Sifilogr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.mrrev.2010.06.002","article-title":"Genetics of Pigmentation in Skin Cancer-A Review","volume":"705","author":"Scherer","year":"2010","journal-title":"Mutat. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.semdp.2015.02.010","article-title":"BRAF V600E Mutation-Specific Antibody: A Review","volume":"32","author":"Ritterhouse","year":"2015","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcb.2013.12.002","article-title":"Oncogenes in Melanoma: An Update","volume":"93","author":"Kunz","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/cncr.30593","article-title":"Somatic Driver Mutations in Melanoma","volume":"123","author":"Reddy","year":"2017","journal-title":"Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12032-016-0879-9","article-title":"KRAS, NRAS and BRAF Mutations in Colorectal Cancer and Melanoma","volume":"34","author":"Cicenas","year":"2017","journal-title":"Med. Oncol. Northwood Lond. Engl."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/path.5213","article-title":"Melanoma Subtypes: Genomic Profiles, Prognostic Molecular Markers and Therapeutic Possibilities","volume":"247","author":"Rabbie","year":"2019","journal-title":"J. Pathol."},{"key":"ref_69","unstructured":"(2015). Cancer Genome Atlas Network Genomic Classification of Cutaneous Melanoma. Cell, 161, 1681\u20131696."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.hoc.2018.09.005","article-title":"Cutaneous Melanoma A Review in Detection, Staging, and Management","volume":"33","author":"Hartman","year":"2019","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1749-6632.1964.tb40991.x","article-title":"Spontaneous Regression of Cancer","volume":"114","author":"Everson","year":"1964","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"viii10","DOI":"10.1093\/annonc\/mds257","article-title":"Melanoma as a Model Tumour for Immuno-Oncology","volume":"23","author":"Maio","year":"2012","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CMR.0b013e32832eabd5","article-title":"Spontaneous Regression of Metastases from Melanoma: Review of the Literature","volume":"19","author":"Kalialis","year":"2009","journal-title":"Melanoma Res."},{"key":"ref_74","first-page":"635","article-title":"Completely Regressed Primary Cutaneous Melanoma-Difficulties in Diagnosis and Classification","volume":"55","author":"Margaritescu","year":"2014","journal-title":"Rom. J. Morphol. Embryol. Rev. Roum. Morphol. Embryol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00000658-195609000-00007","article-title":"Spontaneous Regression of Cancer: Preliminary Report","volume":"144","author":"Cole","year":"1956","journal-title":"Ann. Surg."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fgene.2017.00146","article-title":"The MeLiM Minipig: An Original Spontaneous Model to Explore Cutaneous Melanoma Genetic Basis","volume":"8","author":"Bourneuf","year":"2017","journal-title":"Front. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/CAD.0000000000000526","article-title":"Spontaneous Regression of Malignant Melanoma-Is it Based on the Interplay between Host Immune System and Melanoma Antigens?","volume":"28","author":"Cervinkova","year":"2017","journal-title":"Anticancer. Drugs"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1111\/jdv.13815","article-title":"Regression in Cutaneous Melanoma: A Comprehensive Review from Diagnosis to Prognosis","volume":"30","author":"Ribero","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jcp.2007.049411","article-title":"The Correlation of Regression in Primary Melanoma with sentinel Lymph Node Status","volume":"61","author":"Kaur","year":"2008","journal-title":"J. Clin. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jso.25343","article-title":"Clinical Implications of the Eighth Edition of the American Joint Committee on Cancer Melanoma Staging","volume":"119","author":"Crompton","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbcan.2019.02.002","article-title":"Many Ways to Resistance: How Melanoma Cells Evade Targeted Therapies","volume":"1871","author":"Kozar","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coph.2019.05.010","article-title":"Targeted Therapy for Malignant Melanoma","volume":"46","author":"Lorentzen","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-030-02505-2_2","article-title":"Immunotherapy for Melanoma","volume":"995","author":"Alqusairi","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2019.06.005","article-title":"Reprogramming Lymphocytes for the Treatment of Melanoma: From Biology to Therapy","volume":"141","author":"Margolis","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-18-1550","article-title":"Immunotherapy of Melanoma: Facts and Hopes","volume":"25","author":"Weiss","year":"2019","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3389\/fimmu.2019.00990","article-title":"Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma","volume":"10","author":"Yu","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrc1126","article-title":"Cancer Genetics and Drug Discovery in the Zebrafish","volume":"3","author":"Stern","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/978-3-319-30654-4_23","article-title":"Xiphophorus and Medaka Cancer Models","volume":"916","author":"Schartl","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Bootorabi, F., Manouchehri, H., Changizi, R., Barker, H., Palazzo, E., Saltari, A., Parikka, M., Pincelli, C., and Aspatwar, A. (2017). Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071550"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.devcel.2019.04.013","article-title":"Modeling Cancer with Flies and Fish","volume":"49","author":"Cagan","year":"2019","journal-title":"Dev. Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000370155","article-title":"Drosophila as a Potential Model for Ocular Tumors","volume":"1","author":"Bennett","year":"2015","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0012-1606(81)90470-X","article-title":"A Genetic Melanotic Neoplasm of Drosophila Melanogaster","volume":"83","author":"Hanratty","year":"1981","journal-title":"Dev. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0749.1991.tb00309.x","article-title":"Contributions of the Gordon-Kosswig Melanoma System to the Present Concept of Neoplasia","volume":"4","author":"Anders","year":"1991","journal-title":"Pigment Cell Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.1073\/pnas.86.22.8922","article-title":"Animal Model for Ultraviolet Radiation-Induced Melanoma: Platyfish-Swordtail Hybrid","volume":"86","author":"Setlow","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1073\/pnas.0511248103","article-title":"UV Causation of Melanoma in Xiphophorus is Dominated by Melanin Photosensitized Oxidant Production","volume":"103","author":"Wood","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1002\/j.1460-2075.1992.tb05518.x","article-title":"The Xmrk Receptor Tyrosine Kinase is Activated in Xiphophorus Malignant Melanoma","volume":"11","author":"Wittbrodt","year":"1992","journal-title":"EMBO J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cub.2005.01.031","article-title":"BRAF Mutations are Sufficient to Promote Nevi Formation and Cooperate with p53 in the Genesis of Melanoma","volume":"15","author":"Patton","year":"2005","journal-title":"Curr. Biol. CB"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/zeb.2009.0606","article-title":"Oncogenic NRAS Cooperates with p53 Loss to Generate Melanoma in Zebrafish","volume":"6","author":"Dovey","year":"2009","journal-title":"Zebrafish"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1172\/JCI60434","article-title":"Hooked! Modeling Human Disease in Zebrafish","volume":"122","author":"Santoriello","year":"2012","journal-title":"J. Clin. Invest."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Scahill, C.M., Digby, Z., Sealy, I.M., Wojciechowska, S., White, R.J., Collins, J.E., Stemple, D.L., Bartke, T., Mathers, M.E., and Patton, E.E. (2017). Loss of the Chromatin Modifier Kdm2aa Causes BrafV600E-Independent Spontaneous Melanoma in Zebrafish. PLoS Genetics, 13.","DOI":"10.1371\/journal.pgen.1006959"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1038\/onc.2008.95","article-title":"Catch of the Day: Zebrafish as a Human Cancer Model","volume":"27","author":"Stoletov","year":"2008","journal-title":"Oncogene"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.tcb.2013.09.009","article-title":"Of Fish and Men: Using Zebrafish to Fight Human Diseases","volume":"23","author":"Ablain","year":"2013","journal-title":"Trends Cell Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10456-006-9040-2","article-title":"Human Melanoma Cells Transplanted into Zebrafish Proliferate, Migrate, Produce Melanin, form Masses and Stimulate Angiogenesis in Zebrafish","volume":"9","author":"Haldi","year":"2006","journal-title":"Angiogenesis"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1158\/0008-5472.CAN-14-3319","article-title":"A Quantitative System for Studying Metastasis Using Transparent Zebrafish","volume":"75","author":"Heilmann","year":"2015","journal-title":"Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/jid.2009.213","article-title":"A Mutated EGFR is Sufficient to Induce Malignant Melanoma with Genetic Background-Dependent Histopathologies","volume":"130","author":"Schartl","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Schartl, M., Kneitz, S., Wilde, B., Wagner, T., Henkel, C.V., Spaink, H.P., and Meierjohann, S. (2012). Conserved Expression Signatures between Medaka and Human Pigment Cell Tumors. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037880"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/1523-1747.ep12506432","article-title":"Animal Model of Intracutaneous Melanoma","volume":"78","author":"Levine","year":"1982","journal-title":"J. Invest. Dermatol."},{"key":"ref_108","first-page":"1251","article-title":"Evaluation of Premalignant and Malignant Lesions During the Induction of Mouse Melanomas","volume":"47","author":"Berkelhammer","year":"1987","journal-title":"Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1073\/pnas.88.1.164","article-title":"Malignant Melanoma in Transgenic Mice","volume":"88","author":"Bradl","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1073\/pnas.90.19.8817","article-title":"Transgenic Mouse Model of Malignant Skin Melanoma","volume":"90","author":"Mintz","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1600-0749.1993.tb00619.x","article-title":"Organ-Specific Metastases in Melanoma: Experimental Animal Models","volume":"6","author":"Byers","year":"1993","journal-title":"Pigment Cell Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/1523-1747.ep12340194","article-title":"Spontaneous Melanocytosis in Transgenic Mice","volume":"106","author":"Chen","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1523-1747.1998.00133.x","article-title":"Development of Heritable Melanoma in Transgenic Mice","volume":"110","author":"Zhu","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"ref_114","first-page":"4799","article-title":"A Clinically Relevant, Syngeneic Model of Spontaneous, Highly Metastatic B16 Mouse Melanoma","volume":"5","author":"Bobek","year":"2010","journal-title":"Anticancer Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.prp.2018.07.008","article-title":"Murine Models of Melanoma","volume":"214","author":"Saleh","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"ref_116","first-page":"81","article-title":"Current State of Animal (Mouse) Modeling in Melanoma Research","volume":"8","author":"Kuzu","year":"2015","journal-title":"Cancer Growth Metastasis"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/17460441.2016.1216968","article-title":"Patient-Derived Tumor Xenograft Models for Melanoma Drug Discovery","volume":"11","author":"Harris","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0167-1","article-title":"Studying Cancer Immunotherapy Using Patient-Derived Xenografts (PDXs) in Humanized Mice","volume":"50","author":"Choi","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5732\/cjc.011.10007","article-title":"Animal Models of Melanoma: A Somatic Cell Gene Delivery Mouse Model Allows Rapid Evaluation of Genes Implicated in Human Melanoma","volume":"30","author":"McKinney","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/cncr.30684","article-title":"Genetically Engineered Mouse Models of Melanoma","volume":"123","author":"Day","year":"2017","journal-title":"Cancer"},{"key":"ref_121","first-page":"335","article-title":"Mammalian Models Based on RCAS-TVA Technique","volume":"29","author":"Niu","year":"2008","journal-title":"Zool. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.356","article-title":"Braf(V600E) Cooperates with Pten Loss to Induce Metastatic Melanoma","volume":"41","author":"Dankort","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_123","first-page":"4569","article-title":"Ultraviolet Radiation-Induced Malignant Skin Melanoma in Melanoma-Susceptible Transgenic Mice","volume":"54","author":"Silvers","year":"1994","journal-title":"Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/carcin\/20.9.1747","article-title":"Induction of Melanoma in TPras Transgenic Mice","volume":"20","author":"Gause","year":"1999","journal-title":"Carcinogenesis"},{"key":"ref_125","first-page":"d1531","article-title":"Animal Models of Ultraviolet Radiation (UVR)-Induced Cutaneous Melanoma","volume":"7","author":"Ley","year":"2002","journal-title":"Front. Biosci. J. Virtual Libr."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/jid.2012.221","article-title":"Origin of Mouse Melanomas","volume":"132","author":"Larue","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0738-081X(94)90217-8","article-title":"Pigmented Lesions of the Skin","volume":"12","author":"Goldschmidt","year":"1994","journal-title":"Clin. Dermatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1939-1676.1999.tb02173.x","article-title":"The Molecular Basis of Canine Melanoma: Pathogenesis and Trends in Diagnosis and Therapy","volume":"13","author":"Modiano","year":"1999","journal-title":"J. Vet. Intern. Med."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Prouteau, A., and Andre, C. (2019). Canine Melanomas as Models for Human Melanomas: Clinical, Histological, and Genetic Comparison. Genes, 10.","DOI":"10.3390\/genes10070501"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1354\/vp.39-4-458","article-title":"Expression and Significance of p53, rb, p21\/waf-1, p16\/ink-4a, and PTEN Tumor Suppressors in Canine Melanoma","volume":"39","author":"Koenig","year":"2002","journal-title":"Vet. Pathol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/pcmr.12170","article-title":"Naturally Occurring Melanomas in Dogs as Models for Non-UV Pathways of Human Melanomas","volume":"27","author":"Gillard","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.rvsc.2017.09.009","article-title":"Gene Expression Profiles of Cell Adhesion Molecules, Matrix Metalloproteinases and Their Tissue Inhibitors in Canine Oral Tumors","volume":"113","author":"Pisamai","year":"2017","journal-title":"Res. Vet. Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1038\/s41598-017-06281-1","article-title":"Transcriptome Analysis of Canine Cutaneous Melanoma and Melanocytoma Reveals a Modulation of Genes Regulating Extracellular Matrix Metabolism and Cell Cycle","volume":"7","author":"Brachelente","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Hendricks, W.P.D., Zismann, V., Sivaprakasam, K., Legendre, C., Poorman, K., Tembe, W., Perdigones, N., Kiefer, J., Liang, W., and DeLuca, V. (2018). Somatic Inactivating PTPRJ Mutations and Dysregulated Pathways Identified in Canine Malignant Melanoma by Integrated Comparative Genomic Analysis. PLoS Genetics, 14.","DOI":"10.1371\/journal.pgen.1007589"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1939-1676.1995.tb01087.x","article-title":"Equine Melanocytic Tumors: A Retrospective Study of 53 Horses (1988 to 1991)","volume":"9","author":"Valentine","year":"1995","journal-title":"J. Vet. Intern. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1034\/j.1600-0749.2000.130108.x","article-title":"The Study of Cutaneous Melanomas in Camargue-Type Gray-Skinned Horses (1): Clinical-Pathological Characterization","volume":"13","author":"Fleury","year":"2000","journal-title":"Pigment Cell Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"75","DOI":"10.17221\/5134-CJAS","article-title":"Estimation of Genetic Parameters for Melanoma in the Old Kladruber Horse","volume":"57","author":"Vostry","year":"2012","journal-title":"Czech J. Anim. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Curik, I., Druml, T., Seltenhammer, M., Sundstrom, E., Pielberg, G.R., Andersson, L., and Solkner, J. (2013). Complex Inheritance of Melanoma and Pigmentation of Coat and Skin in Grey Horses. PLoS Genetics, 9.","DOI":"10.1371\/journal.pgen.1003248"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Campagne, C., Jule, S., Bernex, F., Estrada, M., Aubin Houzelstein, G., Panthier, J.J., and Egidy, G. (2012). RACK1, a Clue to the Diagnosis of Cutaneous Melanomas in Horses. BMC Vet. Res., 8.","DOI":"10.1186\/1746-6148-8-95"},{"key":"ref_140","first-page":"345","article-title":"Malignant Melanomas in a Duroc Boar","volume":"170","author":"Thirloway","year":"1977","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0021-9975(78)90004-X","article-title":"Spontaneous Neoplasms of Pigs-A Study of 31 Cases","volume":"88","author":"Fisher","year":"1978","journal-title":"J. Comp. Pathol."},{"key":"ref_142","first-page":"191","article-title":"Malignant Melanomas in Farm Animals","volume":"29","author":"Baba","year":"1983","journal-title":"Morphol. Embryol. (Bucur.)"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1354\/vp.39-4-445","article-title":"Immunohistochemical Characterization of Tumor Cells and Inflammatory Infiltrate Associated with Cutaneous Melanocytic Tumors of Duroc and Iberian Swine","volume":"39","author":"Perez","year":"2002","journal-title":"Vet. Pathol."},{"key":"ref_144","first-page":"301","article-title":"Melanocytic Cutaneous Lesions and Melanotic Regional Lymph Nodes in Slaughter Swine","volume":"54","author":"Bundza","year":"1990","journal-title":"Can. J. Vet. Res. Rev. Can. Rech. Vet."},{"key":"ref_145","first-page":"385","article-title":"Inheritance of Melanocytic Tumors in Duroc Swine","volume":"76","author":"Hordinsky","year":"1985","journal-title":"J. Hered."},{"key":"ref_146","first-page":"165","article-title":"Cutaneous Melanoma in Miniature Swine","volume":"18","author":"Strafuss","year":"1968","journal-title":"Lab. Anim. Care"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/1523-1747.ep12676714","article-title":"Melanoma in Sinclair Swine: A New Animal Model","volume":"62","author":"Millikan","year":"1974","journal-title":"J. Invest. Dermatol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ijc.2910240522","article-title":"Influence of Selective Breeding on the Incidence of Melanomas in Sinclair Miniature Swine","volume":"24","author":"Hook","year":"1979","journal-title":"Int. J. Cancer"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/jnci\/52.5.1559","article-title":"Congenital Cutaneous and Visceral Melanomas of Sinclair Miniature Swine: Three Case Reports","volume":"52","author":"Manning","year":"1974","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_150","first-page":"707","article-title":"Malignant Melanoma in the Sinclair Miniature Swine: An Autopsy Study of 60 Cases","volume":"96","author":"Oxenhandler","year":"1979","journal-title":"Am. J. Pathol."},{"key":"ref_151","first-page":"130","article-title":"Melanoma: Sinclair Swine Melanoma","volume":"108","author":"Hook","year":"1982","journal-title":"Am. J. Pathol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-2427(94)90133-3","article-title":"Sinclair Miniature Swine: An Animal Model of Human Melanoma","volume":"43","author":"Misfeldt","year":"1994","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_153","first-page":"17","article-title":"Histopathology of Regression in Sinclair Swine Model of Melanoma","volume":"71","author":"Greene","year":"1994","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-2427(96)05621-8","article-title":"Immunophenotypic Characterization of Tumor Infiltrating Lymphocytes and Peripheral Blood Lymphocytes Isolated from Melanomatous and Non-Melanomatous Sinclair Miniature Swine","volume":"55","author":"Morgan","year":"1996","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0749.1995.tb00775.x","article-title":"Antimelanoma Antibodies in Swine with Spontaneously Regressing Melanoma","volume":"8","author":"Cui","year":"1995","journal-title":"Pigment Cell Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0021-9975(96)80071-5","article-title":"Cycloheximide-Induced Apoptosis in Melanoma Cells Derived from Regressing Cutaneous Tumours of SINCLAIR Swine","volume":"115","author":"Gossett","year":"1996","journal-title":"J. Comp. Pathol."},{"key":"ref_157","first-page":"1219","article-title":"Spontaneous Regression of Cutaneous Melanoma in Sinclair Swine is Associated with Defective Telomerase Activity and Extensive Telomere Erosion","volume":"17","author":"Pathak","year":"2000","journal-title":"Int. J. Oncol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2052.1989.tb00841.x","article-title":"The Swine Leucocyte Antigen (SLA) Complex and Sinclair Swine Cutaneous Malignant Melanoma","volume":"20","author":"Tissot","year":"1989","journal-title":"Anim. Genet."},{"key":"ref_159","first-page":"5542","article-title":"Inheritance of Sinclair Swine Cutaneous Malignant Melanoma","volume":"47","author":"Tissot","year":"1987","journal-title":"Cancer Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/bjc.1996.116","article-title":"Genetic Determinants of Cutaneous Malignant Melanoma in Sinclair Swine","volume":"73","author":"Blangero","year":"1996","journal-title":"Br. J. Cancer"},{"key":"ref_161","first-page":"53","article-title":"Genetic Predisposition and Specific Chromosomal Defects Associated with Sinclair Swine Malignant Melanomas","volume":"11","author":"Pathak","year":"1997","journal-title":"Int. J. Oncol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1439-0388.2001.00280.x","article-title":"Inheritance of Melanocytic Lesions and Their Association with the White Colour Phenotype in Miniature Swine","volume":"118","author":"Muller","year":"2001","journal-title":"J. Anim. Breed. Genet."},{"key":"ref_163","first-page":"391","article-title":"Segregation of Pigment Cell Anomalies in Munich Miniature Swine (MMS) Troll Crossed with German Landrace","volume":"102","author":"Muller","year":"1995","journal-title":"DTW Dtsch. Tierarztl. Wochenschr."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-2427(91)90055-H","article-title":"Natural Killer (NK) Activity of Porcine Blood Lymphocytes Against Allogeneic Melanoma Target Cells","volume":"29","author":"Buttner","year":"1991","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vetmic.2007.02.024","article-title":"Expression of Porcine Endogenous Retroviruses (PERVs) in Melanomas of Munich Miniature Swine (MMS) Troll","volume":"123","author":"Dieckhoff","year":"2007","journal-title":"Vet. Microbiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1158\/0008-5472.CAN-04-2983","article-title":"Expression of Human Endogenous Retrovirus K in Melanomas and Melanoma Cell Lines","volume":"65","author":"Buscher","year":"2005","journal-title":"Cancer Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"483","DOI":"10.20892\/j.issn.2095-3941.2016.0080","article-title":"Human Endogenous Retroviruses and Cancer","volume":"13","author":"Iduma","year":"2016","journal-title":"Cancer Biol. Med."},{"key":"ref_168","first-page":"23","article-title":"Breeding Program and Population Standards of the Goettingen Miniature Swine","volume":"Volume 1","author":"Tumbleson","year":"1986","journal-title":"Swine in Biomedical Research"},{"key":"ref_169","first-page":"1119","article-title":"Hereditary Melanoblastoma in Miniature Pigs and its Successful Therapy by Devitalization Technique","volume":"45","author":"Horak","year":"1999","journal-title":"Cell. Mol. Biol. Noisy Gd. Fr."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.17221\/5739-VETMED","article-title":"Inheritance of Malignant Melanoma in the MeLiM Strain of Miniature Pigs","volume":"49","author":"Hruban","year":"2004","journal-title":"Vet. Med. (Praha)"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1600-0749.2003.00101.x","article-title":"Clinical and Histopathological Characterization of Cutaneous Melanomas in the Melanoblastoma-Bearing Libechov Minipig Model","volume":"17","author":"Leplat","year":"2004","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/bjs.1800810155","article-title":"Treatment of Malignant Melanoma","volume":"81","author":"Fortyn","year":"1994","journal-title":"Br. J. Surg."},{"key":"ref_173","first-page":"87","article-title":"Exceptional Occurrence and Extent of Malignant Melanoma in Pig","volume":"43","author":"Fortyn","year":"1998","journal-title":"Vet. Med. (Praha)"},{"key":"ref_174","first-page":"597","article-title":"Melanoblastoma in Laboratory Minipigs: A Model for Studying Human Malignant Melan6oma","volume":"39","author":"Fortyn","year":"1994","journal-title":"Vet. Med. (Praha)"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3892\/ol_00000070","article-title":"Melanoma Biomarkers: Vox Clamantis in Deserto (Review)","volume":"1","author":"Gollapudi","year":"2010","journal-title":"Oncol. Lett."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"199","DOI":"10.17221\/7880-VETMED","article-title":"Detection of Neoplastic Cells in Blood of Miniature Pigs with Hereditary Melanoma","volume":"46","author":"Pohlreich","year":"2001","journal-title":"Vet. Med. (Praha)"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2017.01.023","article-title":"Future of Circulating Tumor Cells in the Melanoma Clinical and Research Laboratory Settings","volume":"392","author":"Robertson","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.critrevonc.2014.01.007","article-title":"Detection Methods of Circulating Tumor Cells in Cutaneous Melanoma: A Systematic Review","volume":"91","author":"Rodic","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_179","first-page":"543","article-title":"Biochemical Characterization of a New Melanoma Model-The Minipig MeLiM Strain","volume":"13","author":"Borovansky","year":"2003","journal-title":"Melanoma Res."},{"key":"ref_180","first-page":"631","article-title":"Immunobiology of Melanoma. Gross and Ultrastructural Studies in a New Melanoma Model: The Sinclair Swine","volume":"46","author":"Millikan","year":"1973","journal-title":"Yale J. Biol. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2133.1978.tb06152.x","article-title":"Cellular Fine Structure in the Invasive Nodules of Different Histogenetic Types of Malignant Melanoma","volume":"98","author":"Hunter","year":"1978","journal-title":"Br. J. Dermatol."},{"key":"ref_182","first-page":"349","article-title":"Quantitative Parameters of Melanomas Differentiation","volume":"25","author":"Borovansky","year":"1978","journal-title":"Neoplasma"},{"key":"ref_183","first-page":"1421","article-title":"Inhibition of Tumor Cell Invasion in the Boyden Chamber Assay by a Mannosidase Inhibitor, Mannostatin A","volume":"13","author":"Ochi","year":"1993","journal-title":"Anticancer Res."},{"key":"ref_184","first-page":"1047","article-title":"Disparate behaviour of Two Melanosomal Enzymes (\u03b1-Mannosidase and \u03b3-Glutamyltransferase)","volume":"45","author":"Borovansky","year":"1999","journal-title":"Cell. Mol. Biol. Noisy Gd. Fr."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1476-4598-7-34","article-title":"Transcription Analysis in the MeLiM Swine Model Identifies RACK1 as a Potential Marker of Malignancy for Human Melanocytic Proliferation","volume":"7","author":"Egidy","year":"2008","journal-title":"Mol. Cancer"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3892\/br.2016.732","article-title":"Expression of Microphthalmia Transcription Factor, S100 Protein, and HMB-45 in Malignant Melanoma and Pigmented Nevi","volume":"5","author":"Xia","year":"2016","journal-title":"Biomed. Rep."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1267\/ahc.14020","article-title":"Immunohistochemical Analysis of Collagen IV and Laminin Expression in Spontaneous Melanoma Regression in the Melanoma-Bearing Libechov Minipig","volume":"48","author":"Planska","year":"2015","journal-title":"Acta Histochem. Cytochem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0304-4165(00)00158-6","article-title":"Opposite Regulation of Tenascin-C and Tenascin-X in MeLiM Swine Heritable Cutaneous Malignant Melanoma","volume":"1524","author":"Geffrotin","year":"2000","journal-title":"Biochim. Biophys. Acta BBA Gen. Subj."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.21873\/anticanres.12767","article-title":"Tissue Rebuilding During Spontaneous Regression of Melanoma in the Melanoma-bearing Libechov Minipig","volume":"38","author":"Planska","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/path.1396","article-title":"The Basement Membrane Matrix in Malignancy","volume":"200","author":"Engbring","year":"2003","journal-title":"J. Pathol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.critrevonc.2003.09.006","article-title":"Control of Melanoma Progression by Various Matrikines from Basement Membrane Macromolecules","volume":"49","author":"Pasco","year":"2004","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.biochi.2005.01.013","article-title":"Role of Matrix Metalloproteinases in Melanoma Cell Invasion","volume":"87","author":"Hofmann","year":"2005","journal-title":"Biochimie"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/path.2045","article-title":"Switch to an Invasive Growth Phase in Melanoma is Associated with Tenascin-C, Fibronectin, and Procollagen-I Forming Specific Channel Structures for Invasion","volume":"210","author":"Kaariainen","year":"2006","journal-title":"J. Pathol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4161\/19336918.2014.972781","article-title":"Tenascin-C Signaling in Melanoma","volume":"9","author":"Shao","year":"2014","journal-title":"Cell Adhes. Migr."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"40169","DOI":"10.1038\/srep40169","article-title":"Spatial Mapping of Metals in Tissue-Sections Using Combination of Mass-Spectrometry and Histology Through Image Registration","volume":"7","author":"Anyz","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-4362.1986.tb03449.x","article-title":"Iron, Copper, and Zinc Concentrations in Normal Skin and in Various Nonmalignant and Malignant Lesions","volume":"25","author":"Gorodetsky","year":"1986","journal-title":"Int. J. Dermatol."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Guran, R., Vanickova, L., Horak, V., Krizkova, S., Michalek, P., Heger, Z., Zitka, O., and Adam, V. (2017). MALDI MSI of MeLiM Melanoma: Searching for Differences in Protein Profiles. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0189305"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.3390\/s8053106","article-title":"Utilizing of Adsorptive Transfer Stripping Technique Brdicka Reaction for Determination of Metallothioneins Level in Melanoma Cells, Blood Serum and Tissues","volume":"8","author":"Krizkova","year":"2008","journal-title":"Sensors"},{"key":"ref_199","first-page":"27","article-title":"Metallothionein-Overexpression as a Prognostic Marker in Melanoma","volume":"144","author":"Weinlich","year":"2009","journal-title":"G. Ital. Dermatol. E Venereol. Organo Uff. Soc. Ital. Dermatol. E Sifilogr."},{"key":"ref_200","first-page":"1","article-title":"Relationship Between Haematological Profile and Progression or Spontaneous Regression of Melanoma in the Melanoma-Bearing Libechov Minipigs","volume":"249","author":"Cizkova","year":"2019","journal-title":"Vet. J. Lond. Engl. 1997"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00251-017-1037-z","article-title":"Impact of a CD4 Gene Haplotype on the Immune Response in Minipigs","volume":"70","author":"Blanc","year":"2018","journal-title":"Immunogenetics"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ijc.22289","article-title":"Detection of Novel Quantitative Trait Loci for Cutaneous Melanoma by Genome-Wide Scan in the MeLiM Swine Model","volume":"120","author":"Du","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ijc.10871","article-title":"CDKN2A Region Polymorphism and Genetic Susceptibility to Melanoma in the Melim Swine Model of Familial Melanoma","volume":"103","author":"Renard","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ijc.20053","article-title":"Identification of Five Chromosomal Regions Involved in Predisposition to Melanoma by Genome-Wide Scan in the MeLiM Swine Model","volume":"110","author":"Geffrotin","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s00335-011-9334-6","article-title":"Genetic and Functional Evaluation of MITF as a Candidate Gene for Cutaneous Melanoma Predisposition in Pigs","volume":"22","author":"Bourneuf","year":"2011","journal-title":"Mamm. Genome Off. J. Int. Mamm. Genome Soc."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/age.12136","article-title":"KIT and Melanoma Predisposition in Pigs: Sequence Variants and Association Analysis","volume":"45","author":"Estelle","year":"2014","journal-title":"Anim. Genet."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1593\/neo.08344","article-title":"Gene Expression Signature for Spontaneous Cancer Regression in Melanoma Pigs","volume":"10","author":"Rambow","year":"2008","journal-title":"Neoplasia"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1755-148X.2008.00442.x","article-title":"Identification of Differentially Expressed Genes in Spontaneously Regressing Melanoma Using the MeLiM Swine Model","volume":"21","author":"Rambow","year":"2008","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"27682","DOI":"10.18632\/oncotarget.25455","article-title":"New Susceptibility Loci for Cutaneous Melanoma Risk and Progression Revealed Using a Porcine Model","volume":"9","author":"Bourneuf","year":"2018","journal-title":"Oncotarget"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/JME-13-0063","article-title":"The Regulation and Function of the NUAK Family","volume":"51","author":"Sun","year":"2013","journal-title":"J. Mol. Endocrinol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/ejhg.2013.195","article-title":"Variants at IRX4 as Prostate Cancer Expression Quantitative Trait Loci","volume":"22","author":"Xu","year":"2014","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00018-016-2139-8","article-title":"Functional and Pathological Relevance of HERC Family Proteins: A Decade Later","volume":"73","author":"Schneider","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Fattore, L., Costantini, S., Malpicci, D., Ruggiero, C.F., Ascierto, P.A., Croce, C.M., Mancini, R., and Ciliberto, G. (2017). MicroRNAs in Melanoma Development and Resistance to Target Therapy. Oncotarget, 8.","DOI":"10.18632\/oncotarget.14763"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/pcmr.12243","article-title":"Analysis of Melanoma-Related microRNAs Expression During the Spontaneous Regression of Cutaneous Melanomas in MeLiM Pigs","volume":"27","author":"Baco","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ygyno.2014.01.010","article-title":"The Prognostic Significance of Preoperative Leukocytosis in Epithelial Ovarian Carcinoma: A Retrospective Cohort Study","volume":"132","author":"So","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/CBM-140416","article-title":"The Value of the Pretreatment Neutrophil Lymphocyte Ratio vs. Platelet Lymphocyte Ratio in Predicting the Long-Term Survival in Colorectal Cancer","volume":"14","author":"Azab","year":"2014","journal-title":"Cancer Biomark. Sect. Dis. Markers"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.amjsurg.2015.03.022","article-title":"Clinical Significance of Preoperative Neutrophil-Lymphocyte vs Platelet-Lymphocyte Ratio in Primary Operable Patients with Non-Small Cell Lung Cancer","volume":"210","author":"Zhang","year":"2015","journal-title":"Am. J. Surg."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"8096234","DOI":"10.1155\/2018\/8096234","article-title":"White Blood Cell and Granulocyte Counts Are Independent Predictive Factors for Prognosis of Advanced Pancreatic Caner","volume":"2018","author":"Feng","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00268-013-2418-6","article-title":"Surgical Management of Intraabdominal Metastases from Melanoma: Role of the Neutrophil to Lymphocyte Ratio as a Potential Prognostic Factor","volume":"38","author":"Cananzi","year":"2014","journal-title":"World J. Surg."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ebiom.2017.03.029","article-title":"Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment","volume":"18","author":"Cassidy","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/CMR.0b013e328339da1e","article-title":"Paraneoplastic Granulocytosis in Metastatic Melanoma","volume":"20","author":"Davis","year":"2010","journal-title":"Melanoma Res."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/bjc.2015.180","article-title":"Baseline Neutrophil-To-Lymphocyte Ratio is Associated with Outcome of Ipilimumab-Treated Metastatic Melanoma Patients","volume":"112","author":"Ferrucci","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1245\/s10434-018-6660-x","article-title":"Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study","volume":"25","author":"Wade","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Rachidi, S., Kaur, M., Lautenschlaeger, T., and Li, Z. (2019). Platelet Count Correlates with Stage and Predicts Survival in Melanoma. Platelets, 1\u20135.","DOI":"10.1080\/09537104.2019.1572879"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/01635581.2018.1412475","article-title":"Anemia in Cutaneous Malignant Melanoma: Low Blood Hemoglobin Level is Associated with Nodal Involvement, Metastatic Disease, and Worse Survival","volume":"70","author":"Tas","year":"2018","journal-title":"Nutr. Cancer"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Busti, F., Marchi, G., Ugolini, S., Castagna, A., and Girelli, D. (2018). Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy. Pharm. Basel Switz., 11.","DOI":"10.3390\/ph11040094"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood-2002-04-1260","article-title":"Inappropriate Expression of Hepcidin is Associated with Iron Refractory Anemia: Implications for the Anemia of Chronic Disease","volume":"100","author":"Weinstein","year":"2002","journal-title":"Blood"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.3748\/wjg.v13.i35.4707","article-title":"Iron Overload and Immunity","volume":"13","author":"Porto","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.biocel.2005.02.023","article-title":"Hepcidin: A Direct Link Between Iron Metabolism and Immunity","volume":"37","author":"Vyoral","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the Immune System in Cancer: From Tumor Initiation to Metastatic Progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev."},{"key":"ref_231","first-page":"4155","article-title":"Tumor Infiltrating Lymphocytes: The Regulator of Melanoma Evolution","volume":"17","author":"Antohe","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic Value of Tumor Infiltrating Lymphocytes in the Vertical Growth Phase of Primary Cutaneous Melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ijc.23543","article-title":"Favorable Outcome in Clinically Stage II Melanoma Patients is Associated with the Presence of Activated Tumor Infiltrating T-Lymphocytes and Preserved MHC Class I Antigen Expression","volume":"123","author":"Sluijter","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40425-018-0391-1","article-title":"Adoptive Transfer of Tumor-Infiltrating lymphocytes in Melanoma: A Viable Treatment Option","volume":"6","author":"Rohaan","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.dci.2018.10.001","article-title":"The Role of \u03b1\u03b2 T-Cells in Spontaneous Regression of Melanoma Tumors in Swine","volume":"92","author":"Cizkova","year":"2019","journal-title":"Dev. Comp. Immunol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1189\/jlb.1RU0814-382","article-title":"CD4+\/CD8+ Double-Positive T Cells: More Than Just a Developmental Stage?","volume":"97","author":"Overgaard","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"ref_237","first-page":"305","article-title":"AGE-Dependent Changes in Relative and Absolute Size of Lymphocyte Subsets in the Blood of Pigs from Birth to Slaughter","volume":"55","year":"2011","journal-title":"Bull. Vet. Inst. Pulawy"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood.V91.11.4331","article-title":"Isolation of Tumor-Specific Cytotoxic CD4+ and CD4+CD8dim+ T-Cell Clones Infiltrating a Cutaneous T-Cell Lymphoma","volume":"91","author":"Bagot","year":"1998","journal-title":"Blood"},{"key":"ref_239","first-page":"624143","article-title":"The Influence of the Coexpression of CD4 and CD8 in Cutaneous Lesions on Prognosis of Mycosis Fungoides: A Preliminary Study","volume":"2014","author":"Stinco","year":"2014","journal-title":"J. Skin Cancer"},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Desfran\u00e7ois, J., Moreau Aubry, A., Vignard, V., Godet, Y., Khammari, A., Dreno, B., Jotereau, F., and Gervois, N. (2010). Double Positive CD4CD8 Alphabeta T Cells: A New Tumor-Reactive Population in Human Melanomas. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008437"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrc.2017.13","article-title":"Microbiota: A Key Orchestrator of Cancer Therapy","volume":"17","author":"Roy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S1470-2045(18)30952-5","article-title":"Modulating the Microbiome to Improve Therapeutic Response in Cancer","volume":"20","author":"McQuade","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11912-019-0814-2","article-title":"Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the Microbiome","volume":"21","author":"Warner","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut Microbiome Modulates Response to Anti-PD-1 Immunotherapy in Melanoma Patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1684\/ejd.2015.2696","article-title":"Skin Microbiome in Melanomas and Melanocytic Nevi","volume":"26","author":"Salava","year":"2016","journal-title":"Eur. J. Dermatol. EJD"},{"key":"ref_246","first-page":"285","article-title":"Analysis of Cutaneous Microbiota of Piglets with Hereditary Melanoma","volume":"49","author":"Svejstil","year":"2018","journal-title":"Sci. Agric. Bohem."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12223-018-00670-3","article-title":"Melanoma-Related Changes in Skin Microbiome","volume":"64","author":"Mrazek","year":"2019","journal-title":"Folia Microbiol. (Praha)"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fonc.2018.00371","article-title":"Fusobacterium and Colorectal Cancer","volume":"8","author":"Zhou","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41579-018-0129-6","article-title":"Fusobacterium Nucleatum-Symbiont, Opportunist and Oncobacterium","volume":"17","author":"Brennan","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"346","DOI":"10.5217\/ir.2018.16.3.346","article-title":"Impact of Microbiota in Colorectal Carcinogenesis: Lessons from Experimental Models","volume":"16","author":"Yu","year":"2018","journal-title":"Intest. Res."},{"key":"ref_251","first-page":"34","article-title":"Experimental Elimination of Various Intestinal Segments by Means of Devascularization (Devitalization)","volume":"18","author":"Fortyn","year":"1985","journal-title":"Z. Exp. Chir. Transplant. Kunstl. Organe Organ Sekt. Exp. Chir. Ges. Chir. DDR"},{"key":"ref_252","first-page":"42","article-title":"Small and Large Intestine Devascularization (Devitalization) and Potentials in the Therapeutic Use of this Operative Method","volume":"18","author":"Fortyn","year":"1985","journal-title":"Z. Exp. Chir. Transplant. Kunstl. Organe Organ Sekt. Exp. Chir. Ges. Chir. DDR"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3892\/mco.2016.1033","article-title":"Autologous Tumor Immunizing Devascularization of an Invasive Colorectal Cancer: A Case Report and Literature Review","volume":"5","author":"Vasek","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02549672","article-title":"Morphology of Regressive Changes in the Kidney Following Experimental Ischaemia","volume":"19","author":"Fortyn","year":"1987","journal-title":"Int. Urol. Nephrol."},{"key":"ref_255","first-page":"275","article-title":"A Technique of the Segmental Devitalization of Kidneys in Experiment","volume":"21","author":"Fortyn","year":"1988","journal-title":"Z. Exp. Chir. Transplant. Kunstl. Organe Organ Sekt. Exp. Chir. Ges. Chir. DDR"},{"key":"ref_256","first-page":"163","article-title":"The Devitalization of the Stomach by a Devascularization Technique","volume":"29","author":"Fortyn","year":"1988","journal-title":"Acta Chir. Hung."},{"key":"ref_257","first-page":"173","article-title":"Experimental Devascularization (Devitalization) of the Rectum and Sigmoideum","volume":"22","author":"Fortyn","year":"1989","journal-title":"Z. Exp. Chir. Transplant. Kunstl. Organe Organ Sekt. Exp. Chir. Ges. Chir. DDR"},{"key":"ref_258","unstructured":"Horak, V., Moravkova, A., Strnadel, J., Hradecky, J., Usvald, D., and Vannucci, L. (2008, January 15\u201316). Devitalization as a Special Surgical Tumour Treatment Inducing Anti-Cancer Response\u2013An Experimental Study in Two Animal Models. Proceedings of the CIMT Cancer Immunotherapy 6th Annual Meeting, Mainz, Germany."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00188611","article-title":"Heat Shock Proteins Transfer Peptides During Antigen Processing and CTL Priming","volume":"39","author":"Srivastava","year":"1994","journal-title":"Immunogenetics"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"17163","DOI":"10.1074\/jbc.M011547200","article-title":"Heat Shock Protein-Chaperoned Peptides but not Free Peptides Introduced into the Cytosol are Presented Efficiently by Major Histocompatibility Complex I Molecules","volume":"276","author":"Binder","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_261","first-page":"629","article-title":"The Role of Heat Shock Proteins and Their Receptors in the Activation of the Immune System","volume":"382","author":"Hilf","year":"2001","journal-title":"Biol. Chem."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1586\/14760584.2.3.369","article-title":"Vaccination with Heat Shock Protein-Peptide Complexes: From Basic Science to Clinical Applications","volume":"2","author":"Hoos","year":"2003","journal-title":"Expert Rev. Vaccines"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2007.11.9941","article-title":"Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, with Physician\u2019s Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group","volume":"26","author":"Testori","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1586\/erv.09.108","article-title":"HSPPC-96 Vaccine in Metastatic Melanoma Patients: From the State of the Art to a Possible Future","volume":"8","author":"Tosti","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1517\/14712598.2011.605353","article-title":"The Immunological era in Melanoma Treatment: New Challenges for Heat Shock Protein-Based Vaccine in the Advanced Disease","volume":"11","author":"Tosti","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fimmu.2016.00171","article-title":"Heat Shock Protein-Peptide and HSP-Based Immunotherapies for the Treatment of Cancer","volume":"7","author":"Shevtsov","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_267","first-page":"245","article-title":"Genetically Modified Pigs for Medicine and Agriculture","volume":"25","author":"Prather","year":"2008","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s13353-013-0182-9","article-title":"Genetically Modified Pigs to Model Human Diseases","volume":"55","author":"Flisikowska","year":"2014","journal-title":"J. Appl. Genet."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fgene.2016.00078","article-title":"Engineered Swine Models of Cancer","volume":"7","author":"Watson","year":"2016","journal-title":"Front. Genet."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fonc.2017.00190","article-title":"The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform","volume":"7","author":"Schachtschneider","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1196\/annals.1334.015","article-title":"The Miniature Pig as an Animal Model in Biomedical Research","volume":"1049","author":"Vodicka","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/11\/915\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:33:10Z","timestamp":1760189590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/10\/11\/915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,9]]},"references-count":271,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["genes10110915"],"URL":"https:\/\/doi.org\/10.3390\/genes10110915","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,9]]}}}